NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare skin disease: first human trial of BCX17725 begins
Disease control Recruiting nowThis early-stage study tests a new drug called BCX17725 for Netherton syndrome, a rare genetic condition that causes severe skin redness and scaling. The trial first checks safety in healthy adults, then tests the drug in people with the condition to see if it improves skin sympt…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 20:24 UTC
-
New cream shows promise for rare skin disorder
Symptom relief Recruiting nowThis early-stage study tests a new cream called ATR12-351 in 12 adults with Netherton Syndrome, a rare genetic skin condition. The cream is applied to skin lesions twice daily for two weeks, with a placebo cream used on other areas for comparison. The main goals are to check safe…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC